Provided by Tiger Trade Technology Pte. Ltd.

Tema Heart & Health ETF

36.22
+0.51001.43%
Post-market: 36.220.00000.00%19:30 EDT
Volume:683
Turnover:24.64K
Market Cap:53.60M
PE:- -
High:36.22
Open:35.75
Low:35.75
Close:35.71
52wk High:38.87
52wk Low:31.87
Shares:1.48M
Float Shares:1.48M
Volume Ratio:0.23
T/O Rate:0.05%
Dividend:0.47
Dividend Rate:1.31%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Waters Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
4 hours ago

Sector Update: Healthcare

MT Newswires Live
·
8 hours ago

Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand

MT Newswires Live
·
9 hours ago

UnitedHealth Price Target Cut to $402.00/Share from $430.00 by TD Cowen

Dow Jones
·
9 hours ago

Millions of Americans Will Have Fewer Options During Medicare Open Enrollment This Year

Dow Jones
·
Yesterday

1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults

Dow Jones
·
Yesterday

BofA Securities Adjusts Eli Lilly Price Target to $1,341 From $1,344, Maintains Buy Rating

MT Newswires Live
·
Yesterday

UnitedHealth, Amazon.Com Inc. Share Gains Contribute to Dow's 138-Point Jump

Dow Jones
·
Yesterday

Merck & Company (MRK) Receives a Buy from UBS

TIPRANKS
·
Yesterday

UnitedHealth price target lowered to $402 from $430 at TD Cowen

TIPRANKS
·
Yesterday

U.S. Stocks on the MOVE-SpaceX, Humana, Delta Air Lines

Reuters
·
Yesterday

Piper Sandler recommends buying UnitedHealth on 2027 Star Ratings release

TIPRANKS
·
Yesterday

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NVST), Bristol-Myers Squibb (BMY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Eli Lilly announces new TOGETHER-PsO trial data

TIPRANKS
·
Yesterday

Merck price target lowered to $163 from $166 at BofA

TIPRANKS
·
Yesterday

Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone

Reuters
·
Yesterday

Eli Lilly price target lowered to $1,341 from $1,344 at BofA

TIPRANKS
·
Yesterday

Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity

THOMSON REUTERS
·
Yesterday

Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine

THOMSON REUTERS
·
Yesterday

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Advance Understanding of the Interconnected Immune and Metabolic Biology in Adults with Psoriasis and Obesity

THOMSON REUTERS
·
Yesterday